Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
RTX Corporation's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $270.6B | |
|---|---|---|
| Revenue (ttm) | 96B | |
| Net income (ttm) | 8.4B | |
| EPS (ttm) | $6.15 | |
| Shares out | 1.3B | |
| P/E (trailing) | 31.8x | |
| P/E (forward) | 26.0x | |
| Dividend | $2.92 (1.49%) | |
| Volume | 3,534,037 | |
| Beta | 0.31 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $64.39B | $67.07B | $68.92B | $80.74B | $88.60B | +8.3% |
| Gross profit | $12.49B | $13.67B | $12.09B | $15.41B | $17.79B | +9.2% |
| Operating income | $5.14B | $5.50B | $3.56B | $6.54B | $9.30B | +16.0% |
| Net income | $3.86B | $5.20B | $3.20B | $4.77B | $6.73B | +14.9% |
| EPS (diluted) | $2.56 | $3.50 | $2.23 | $3.55 | $4.96 | +18.0% |
| EBITDA | $11.00B | $11.53B | $3.56B | $12.53B | $14.95B | +8.0% |
| R&D | $2.73B | $2.71B | $2.81B | $2.93B | $2.81B | +0.7% |
| SG&A | $5.05B | $5.57B | $5.81B | $5.81B | $6.10B | +4.8% |
Recent company headlines from major financial publishers.
The path fails if either FY2027 measure falls below its analyst mean as of 2026-09-09.
That result would support a longer earnings runway. The case would weaken if either FY2027 measure missed its upper endpoint as of 2026-09-09 or operating cash no longer exceeded reported profit relative to that 2026-09-06 baseline.
| Ke ↓ / g → | 2.6% | 3.1% | 3.6% | 4.1% | 4.6% |
|---|---|---|---|---|---|
| 5.6% | $293 | $340 | $422 | $614 | $689 |
| 6.6% | $229 | $251 | $281 | $327 | $406 |
| 7.6% | $193 | $205 | $222 | $241 | $270 |
| 8.6% | $169 | $176 | $186 | $197 | $212 |
| 9.5% | $152 | $157 | $163 | $170 | $179 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
